Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study

Diabetologia

Volumn 58, Issue 12, 2015, Pages 2745-2752

  DeBoer, Mark D ^a   Gurka, Matthew J ^b   Woo, Jessica G ^c   Morrison, John A ^d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Insulin resistance; Metabolic syndrome; Risk; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADOLESCENT; ADULT; ADULT DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; MALE; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84946497684     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3759-5     Document Type: Article

References (42)

1. Popkin BM (2012) Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 70:3–21
2. Cefalu WT (2012) Steps toward the meaningful translation of prevention strategies for type 2 diabetes. Diabetes Care 35:663–665
3. DeBoer MD (2013) Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 29:379–386
4. Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome – an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752
5. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251–1257
6. Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374
7. de Ferranti S, Mozaffarian D (2008) The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54:945–955
8. Tilg H, Moschen AR (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14:222–231
9. Morrison JA, Friedman LA, Wang P, Glueck CJ (2008) Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 152:201–206
10. Morrison JA, Friedman LA, Gray-McGuire C (2007) Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: The Princeton Lipid Research Clinics follow-up study. Pediatrics 120:340–345
11. Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005) Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644–2650
12. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F (2002) Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis – The Atherosclerosis Risk in Communities Study. Diabetes 51:3069–3076
13. Simons LA, Simons J, Friedlander Y, McCallum J (2011) Is prediction of cardiovascular disease and all-cause mortality genuinely driven by the metabolic syndrome, and independently from its component variables? The Dubbo Study. Heart Lung Circ 20:214–219
14. McNeill AM, Schmidt MI, Rosamond WD et al (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28:385–390
15. Malik S, Wong ND, Franklin SS et al (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:1245–1250
16. Gustafson JK, Yanoff LB, Easter BD et al (2009) The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab 94:4828–4834
17. Li C, Ford ES, Huang TTK, Sun SS, Goodman E (2009) Patterns of change in cardiometabolic risk factors associated with the metabolic syndrome among children and adolescents: the Fels Longitudinal Study. J Pediatr 155:S5.e9-16
18. Walker SE, Gurka MJ, Oliver MN, Johns DW, DeBoer MD (2012) Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis 22:141–148
19. DeBoer MD, Dong L, Gurka MJ (2011) Racial/ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents. J Pediatr 159:975–981
20. DeBoer MD, Gurka MJ, Sumner AE (2011) Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in non-Hispanic black adolescents: an analysis of NHANES 1999-2008. Diabetes Care 34:734–740
21. DeBoer MD, Gurka MJ (2012) Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: an analysis of NHANES 1999-2006. Atherosclerosis 220:575–580
22. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB (2005) State of disparities in cardiovascular health in the United States. Circulation 111:1233–1241
23. Cowie CC, Rust KF, Byrd-Holt DD et al (2010) Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 33:562–568
24. Sumner AE (2009) Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr 155:S7.e7–e11
25. Gurka MJ, Ice CL, Sun SS, DeBoer MD (2012) A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol 11:128
26. Gurka MJ, Lilly CL, Oliver MN, DeBoer MD (2014) An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metab Clin Exp 63:218–225
27. Eisenmann JC (2008) On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 7:17
28. Okosun IS, Lyn R, Davis-Smith M, Eriksen M, Seale P (2010) Validity of a continuous metabolic risk score as an index for modeling metabolic syndrome in adolescents. Ann Epidemiol 20:843–851
29. DeBoer MD, Gurka MJ, Woo JG, Morrison JA (2015) Severity of metabolic syndrome as a predictor of cardiovascular disease between childhood and adulthood: the Princeton Lipid Research Cohort Study. J Am Coll Cardiol 66:755–757
30. Morrison J, Degroot I, Kelly K, Mellies M, Glueck CJ (1978) Parent–child associations at upper and lower ranges of plasma cholesterol and triglyceride levels. Pediatrics 62:468–477
31. Woo JG, Morrison JA, Stroop DM, Aronson Friedman L, Martin LJ (2014) Genetic architecture of lipid traits changes over time and differs by race: Princeton Lipid Follow-up Study. J Lipid Res 55:1515–1524
32. Laskarzewski P, Morrison JA, Mellies MJ et al (1980) Relationships of measurements of body-mass to plasma-lipoproteins in school-children and adults. Am J Epidemiol 111:395–406
33. Barthelmai W, Czok R (1962) Enzymatische Bestimmungen der Glucose in Blut, Liquor und Harn. Klin Wochenscr 40:585–589, article in German
34. Sacks DB (1999) Carbohydrates. WB Saunders, Philadelphia
35. Ford ES, Li C, Cook S, Choi HK (2007) Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115:2526–2532
36. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576
37. Bassi N, Karaqodin I, Wang S et al (2014) Lifestyle modification for metabolic syndrome: a systematic review. Am J Med 127:1242.e1–10
38. Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132
39. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
40. DeBoer MD, Gurka MJ (2010) Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999–2006. Metab Syndr Relat Disord 8:343–353
41. Janiszewski PM, Janssen I, Ross R (2007) Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care 30:3105–3109
42. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298:299–308